{"PubmedArticle": [{"MedlineCitation": {"KeywordList": [["gastrointestinal tumours", "ginseng", "ginsenosides", "molecular mechanism", "natural medicine"]], "GeneralNote": [], "OtherAbstract": [], "CitationSubset": [], "SpaceFlightMission": [], "OtherID": [], "InvestigatorList": [], "PMID": "36313365", "DateRevised": {"Year": "2022", "Month": "11", "Day": "02"}, "Article": {"ArticleDate": [{"Year": "2022", "Month": "10", "Day": "12"}], "Language": ["eng"], "ELocationID": ["1036498", "10.3389/fphar.2022.1036498"], "Journal": {"ISSN": "1663-9812", "JournalIssue": {"Volume": "13", "PubDate": {"Year": "2022"}}, "Title": "Frontiers in pharmacology", "ISOAbbreviation": "Front Pharmacol"}, "ArticleTitle": "Research progress of ginseng in the treatment of gastrointestinal cancers.", "Pagination": {"StartPage": "1036498", "MedlinePgn": "1036498"}, "Abstract": {"AbstractText": ["Cancer has become one of the major causes of human death. Several anticancer drugs are available; howeve their use and efficacy are limited by the toxic side effects and drug resistance caused by their continuous application. Many natural products have antitumor effects with low toxicity and fewer adverse effects. Moreover, they play an important role in enhancing the cytotoxicity of chemotherapeutic agents, reducing toxic side effects, and reversing chemoresistance. Consequently, natural drugs are being applied as potential therapeutic options in the field of antitumor treatment. As natural medicinal plants, some components of ginseng have been shown to have excellent efficacy and a good safety profile for cancer treatment. The pharmacological activities and possible mechanisms of action of ginseng have been identified. Its broad range of pharmacological activities includes antitumor, antibacterial, anti-inflammatory, antioxidant, anti-stress, anti-fibrotic, central nervous system modulating, cardioprotective, and immune-enhancing effects. Numerous studies have also shown that throuth multiple pathways, ginseng and its active ingredients exert antitumor effects on gastrointestinal (GI) tract tumors, such as esophageal, gastric, colorectal, liver, and pancreatic cancers. Herein, we introduced the main components of ginseng, including ginsenosides, polysaccharides, and sterols, etc., and reviewed the mechanism of action and research progress of ginseng in the treatment of various GI tumors. Futhermore, the pathways of action of the main components of ginseng are discussed in depth to promote the clinical development and application of ginseng in the field of anti-GI tumors."], "CopyrightInformation": "Copyright \u00a9 2022 Ni, Song, Shi, Wang, Sun, Wang, Xu, Cao, Zhu and Li."}, "AuthorList": [{"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Guang'anmen Hospital, China Academy of Chinese Medical Sciences, Beijing, China."}], "LastName": "Ni", "ForeName": "Baoyi", "Initials": "B"}, {"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Guang'anmen Hospital, China Academy of Chinese Medical Sciences, Beijing, China."}], "LastName": "Song", "ForeName": "Xiaotong", "Initials": "X"}, {"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Guang'anmen Hospital, China Academy of Chinese Medical Sciences, Beijing, China."}], "LastName": "Shi", "ForeName": "Bolun", "Initials": "B"}, {"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Hongqi Hospital of Mudanjiang Medical University, Mudanjiang, China."}], "LastName": "Wang", "ForeName": "Jia", "Initials": "J"}, {"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Guang'anmen Hospital, China Academy of Chinese Medical Sciences, Beijing, China."}], "LastName": "Sun", "ForeName": "Qianhui", "Initials": "Q"}, {"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Guang'anmen Hospital, China Academy of Chinese Medical Sciences, Beijing, China."}], "LastName": "Wang", "ForeName": "Xinmiao", "Initials": "X"}, {"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Guang'anmen Hospital, China Academy of Chinese Medical Sciences, Beijing, China."}], "LastName": "Xu", "ForeName": "Manman", "Initials": "M"}, {"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Guang'anmen Hospital, China Academy of Chinese Medical Sciences, Beijing, China."}], "LastName": "Cao", "ForeName": "Luchang", "Initials": "L"}, {"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Guang'anmen Hospital, China Academy of Chinese Medical Sciences, Beijing, China."}, {"Identifier": [], "Affiliation": "Hongqi Hospital of Mudanjiang Medical University, Mudanjiang, China."}], "LastName": "Zhu", "ForeName": "Guanghui", "Initials": "G"}, {"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Guang'anmen Hospital, China Academy of Chinese Medical Sciences, Beijing, China."}], "LastName": "Li", "ForeName": "Jie", "Initials": "J"}], "PublicationTypeList": ["Journal Article", "Review"]}, "MedlineJournalInfo": {"Country": "Switzerland", "MedlineTA": "Front Pharmacol", "NlmUniqueID": "101548923", "ISSNLinking": "1663-9812"}}, "PubmedData": {"ReferenceList": [{"Reference": [{"Citation": "Ahmed E. A., Rajendran P., Scherthan H. (2022). The microRNA-202 as a diagnostic biomarker and a potential tumor suppressor. Int. J. Mol. Sci. 23 (11), 5870. 10.3390/ijms23115870", "ArticleIdList": ["10.3390/ijms23115870", "PMC9180238", "35682549"]}, {"Citation": "Almeer R. S., Aref A. M., Hussein R. A., Othman M. S., Abdel M. A. (2019). Antitumor potential of berberine and cinnamic acid against solid ehrlich carcinoma in mice. Anticancer. Agents Med. Chem. 19 (3), 356\u2013364. 10.2174/1871520618666181116162441", "ArticleIdList": ["10.2174/1871520618666181116162441", "30451117"]}, {"Citation": "Amano R., Yamashita A., Kasai H., Hori T., Miyasato S., Saito S., et al. (2017). Cinnamic acid derivatives inhibit hepatitis C virus replication via the induction of oxidative stress. Antivir. Res. 145, 123\u2013130. 10.1016/j.antiviral.2017.07.018", "ArticleIdList": ["10.1016/j.antiviral.2017.07.018", "28780423"]}, {"Citation": "Amin E., Jaiswal M., Derewenda U., Reis K., Nouri K., Koessmeier K. T., et al. (2016). Deciphering the molecular and functional basis of rhogap family proteins: A systematic approach toward selective inactivation of Rho family proteins. J. Biol. Chem. 291 (39), 20353\u201320371. 10.1074/jbc.M116.736967", "ArticleIdList": ["10.1074/jbc.M116.736967", "PMC5034035", "27481945"]}, {"Citation": "Anantharaju P. G., Reddy D. B., Padukudru M. A., Chitturi C., Vimalambike M. G., Madhunapantula S. V. (2017). Induction of colon and cervical cancer cell death by cinnamic acid derivatives is mediated through the inhibition of Histone Deacetylases (HDAC). PLoS One 12 (11), e0186208. 10.1371/journal.pone.0186208", "ArticleIdList": ["10.1371/journal.pone.0186208", "PMC5708809", "29190639"]}, {"Citation": "Andima M., Costabile G., Isert L., Ndakala A. J., Derese S., Merkel O. M. (2018). Evaluation of beta-sitosterol loaded PLGA and PEG-PLA nanoparticles for effective treatment of breast cancer: Preparation, physicochemical characterization, and antitumor activity. Pharmaceutics 10 (4), E232. 10.3390/pharmaceutics10040232", "ArticleIdList": ["10.3390/pharmaceutics10040232", "PMC6321471", "30445705"]}, {"Citation": "Antwi A. O., Obiri D. D., Osafo N., Essel L. B., Forkuo A. D., Atobiga C. (2018). Stigmasterol alleviates cutaneous allergic responses in rodents. Biomed. Res. Int. 2018, 3984068. 10.1155/2018/3984068", "ArticleIdList": ["10.1155/2018/3984068", "PMC6081592", "30140696"]}, {"Citation": "Antwi A. O., Obiri D. D., Osafo N., Forkuo A. D., Essel L. B. (2017). Stigmasterol inhibits lipopolysaccharide-induced innate immune responses in murine models. Int. Immunopharmacol. 53, 105\u2013113. 10.1016/j.intimp.2017.10.018", "ArticleIdList": ["10.1016/j.intimp.2017.10.018", "29078089"]}, {"Citation": "Ashrafizadeh M., Ahmadi Z., Yaribeygi H., Sathyapalan T., Jamialahmadi T., Sahebkar A. (2021). The effects of ginsenosides on the Nrf2 signaling pathway. Adv. Exp. Med. Biol. 1328, 307\u2013322. 10.1007/978-3-030-73234-9_20", "ArticleIdList": ["10.1007/978-3-030-73234-9_20", "34981486"]}, {"Citation": "Aziz F., Wang X., Liu J., Yan Q. (2016). Ginsenoside Rg3 induces FUT4-mediated apoptosis in H. pylori CagA-treated gastric cancer cells by regulating SP1 and HSF1 expressions. Toxicol. Vitro. 31, 158\u2013166. 10.1016/j.tiv.2015.09.025", "ArticleIdList": ["10.1016/j.tiv.2015.09.025", "26427350"]}, {"Citation": "Bae H., Park S., Ham J., Song J., Hong T., Choi J. H., et al. (2021). ER-mitochondria calcium flux by beta-sitosterol promotes cell death in ovarian cancer. Antioxidants (Basel) 10 (10), 1583. 10.3390/antiox10101583", "ArticleIdList": ["10.3390/antiox10101583", "PMC8533280", "34679718"]}, {"Citation": "Bae H., Song G., Lim W. (2020). Stigmasterol causes ovarian cancer cell apoptosis by inducing endoplasmic reticulum and mitochondrial dysfunction. Pharmaceutics 12 (6), E488. 10.3390/pharmaceutics12060488", "ArticleIdList": ["10.3390/pharmaceutics12060488", "PMC7356731", "32481565"]}, {"Citation": "Bai Z., Yao C., Zhu J., Xie Y., Ye X. Y., Bai R., et al. (2021). Anti-tumor drug discovery based on natural product beta-elemene: Anti-tumor mechanisms and structural modification. Molecules 26 (6), 1499. 10.3390/molecules26061499", "ArticleIdList": ["10.3390/molecules26061499", "PMC7998186", "33801899"]}, {"Citation": "Banyard J., Bielenberg D. R. (2015). The role of EMT and MET in cancer dissemination. Connect. Tissue Res. 56 (5), 403\u2013413. 10.3109/03008207.2015.1060970", "ArticleIdList": ["10.3109/03008207.2015.1060970", "PMC4780319", "26291767"]}, {"Citation": "Bin S. M., Ameen S. S. (2015). Beta-sitosterol: A promising but orphan nutraceutical to fight against cancer. Nutr. Cancer. 67 (8), 1214\u20131220. 10.1080/01635581.2015.1087042", "ArticleIdList": ["10.1080/01635581.2015.1087042", "26473555"]}, {"Citation": "Bomfim D. S., Ferraz R. P., Carvalho N. C., Soares M. B., Pinheiro M. L., Costa E. V., et al. (2013). Eudesmol isomers induce caspase-mediated apoptosis in human hepatocellular carcinoma HepG2 cells. Basic Clin. Pharmacol. Toxicol. 113 (5), 300\u2013306. 10.1111/bcpt.12097", "ArticleIdList": ["10.1111/bcpt.12097", "23786320"]}, {"Citation": "Boubaker J., Ben T. I., Sassi A., Bzouich-Mokded I., Ghoul M. S., Sioud F., et al. (2018). Antitumoral potency by immunomodulation of chloroform extract from leaves of nitraria retusa, Tunisian medicinal plant, via its major compounds beta-sitosterol and palmitic acid in BALB/c mice bearing induced tumor. Nutr. Cancer. 70 (4), 650\u2013662. 10.1080/01635581.2018.1460683", "ArticleIdList": ["10.1080/01635581.2018.1460683", "29697283"]}, {"Citation": "Cai J., Jing J., Lu Y., Du R. (2007). Research progress of natural polyacetylene alcohol. Tianjin: Chinese Traditional and Herbal Drugs, 620\u2013623.04."}, {"Citation": "Cao Y., Ye Q., Zhuang M., Xie S., Zhong R., Cui J., et al. (2017). Ginsenoside Rg3 inhibits angiogenesis in a rat model of endometriosis through the VEGFR-2-mediated PI3K/Akt/mTOR signaling pathway. PLoS One 12 (11), e0186520. 10.1371/journal.pone.0186520", "ArticleIdList": ["10.1371/journal.pone.0186520", "PMC5687597", "29140979"]}, {"Citation": "Cao Z. Q., Wang X. X., Lu L., Xu J. W., Li X. B., Zhang G. R., et al. (2020). Corrigendum: \u03b2-Sitosterol and gemcitabine exhibit synergistic anti-pancreatic cancer activity by modulating apoptosis and inhibiting epithelial-mesenchymal transition by deactivating akt/GSK-3\u03b2 signaling. Front. Pharmacol. 11, 565535. 10.3389/fphar.2020.565535", "ArticleIdList": ["10.3389/fphar.2020.565535", "PMC7919186", "33658921"]}, {"Citation": "Chen C C., Lv Q., Li Y., Jin Y. H. (2021). The anti-tumor effect and underlying apoptotic mechanism of ginsenoside Rk1 and Rg5 in human liver cancer cells. Molecules 26 (13), 3926. 10.3390/molecules26133926", "ArticleIdList": ["10.3390/molecules26133926", "PMC8271777", "34199025"]}, {"Citation": "Chen H., Yang H., Deng J., Fan D. (2021). Ginsenoside Rk3 ameliorates obesity-induced colitis by regulating of intestinal flora and the TLR4/NF-\u03baB signaling pathway in C57bl/6 mice. J. Agric. Food Chem. 69 (10), 3082\u20133093. 10.1021/acs.jafc.0c07805", "ArticleIdList": ["10.1021/acs.jafc.0c07805", "33621094"]}, {"Citation": "Chen P., Li X., Zhang R., Liu S., Xiang Y., Zhang M., et al. (2020). Combinative treatment of beta-elemene and cetuximab is sensitive to KRAS mutant colorectal cancer cells by inducing ferroptosis and inhibiting epithelial-mesenchymal transformation. Theranostics 10 (11), 5107\u20135119. 10.7150/thno.44705", "ArticleIdList": ["10.7150/thno.44705", "PMC7163451", "32308771"]}, {"Citation": "Chen W., Chu S., Li H., Qiu Y. (2018). MicroRNA-146a-5p enhances ginsenoside Rh2-induced anti-proliferation and the apoptosis of the human liver cancer cell line HepG2. Oncol. Lett. 16 (4), 5367\u20135374. 10.3892/ol.2018.9235", "ArticleIdList": ["10.3892/ol.2018.9235", "PMC6126334", "30197683"]}, {"Citation": "Chen X., Xu T., Lv X., Zhang J., Liu S. (2021). Ginsenoside Rh2 alleviates ulcerative colitis by regulating the STAT3/miR-214 signaling pathway. J. Ethnopharmacol. 274, 113997. 10.1016/j.jep.2021.113997", "ArticleIdList": ["10.1016/j.jep.2021.113997", "33705918"]}, {"Citation": "Cheng H., Ge X., Zhuo S., Gao Y., Zhu B., Zhang J., et al. (2018). \u03b2-Elemene synergizes with gefitinib to inhibit stem-like phenotypes and progression of lung cancer via down-regulating EZH2. Front. Pharmacol. 9, 1413. 10.3389/fphar.2018.01413", "ArticleIdList": ["10.3389/fphar.2018.01413", "PMC6284059", "30555330"]}, {"Citation": "Cheng H., Li S., Fan Y., Gao X., Hao M., Wang J., et al. (2011). Comparative studies of the antiproliferative effects of ginseng polysaccharides on HT-29 human colon cancer cells. Med. Oncol. 28 (1), 175\u2013181. 10.1007/s12032-010-9449-8", "ArticleIdList": ["10.1007/s12032-010-9449-8", "20165990"]}, {"Citation": "Cheng L., Li H., Kong L., Yang J., Kang T., Zhang J. (2016). Ginseng proteins synergize with H_2O_2 to induce oxidative damage in SH-SY5Y cells. Chin. J. Hosp. Pharm. | Chin J Hosp Pharm. 36 (09), 707\u2013710."}, {"Citation": "Cheng Z., Xing D. (2019). Retracted: Ginsenoside Rg3 inhibits growth and epithelial-mesenchymal transition of human oral squamous carcinoma cells by down-regulating miR-221. Eur. J. Pharmacol. 853, 353\u2013363. 10.1016/j.ejphar.2019.03.040", "ArticleIdList": ["10.1016/j.ejphar.2019.03.040", "30928631"]}, {"Citation": "Cong Z., Zhao Q., Yang B., Cong D., Zhou Y., Lei X., et al. (2020). Ginsenoside Rh3 inhibits proliferation and induces apoptosis of colorectal cancer cells. Pharmacology 105 (5-6), 329\u2013338. 10.1159/000503821", "ArticleIdList": ["10.1159/000503821", "31671429"]}, {"Citation": "Conlon G. A., Murray G. I. (2019). Recent advances in understanding the roles of matrix metalloproteinases in tumour invasion and metastasis. J. Pathol. 247 (5), 629\u2013640. 10.1002/path.5225", "ArticleIdList": ["10.1002/path.5225", "30582157"]}, {"Citation": "Cuypers A., Truong A. K., Becker L. M., Saavedra-Garcia P., Carmeliet P. (2022). Tumor vessel co-option: The past & the future. Front. Oncol. 12, 965277. 10.3389/fonc.2022.965277", "ArticleIdList": ["10.3389/fonc.2022.965277", "PMC9472251", "36119528"]}, {"Citation": "de Oliveira J. R., Christiane A. A., Da S. A. J., Grougnet R., Thiery V., Picot L. (2018). Sensitization of tumor cells to chemotherapy by natural products: A systematic review of preclinical data and molecular mechanisms. Fitoterapia 129, 383\u2013400. 10.1016/j.fitote.2018.02.025", "ArticleIdList": ["10.1016/j.fitote.2018.02.025", "29476786"]}, {"Citation": "De Wang X., Li T., Li Y., Yuan W. H., Zhao Y. Q. (2020). 2-Pyrazine-PPD, a novel dammarane derivative, showed anticancer activity by reactive oxygen species-mediate apoptosis and endoplasmic reticulum stress in gastric cancer cells. Eur. J. Pharmacol. 881, 173211. 10.1016/j.ejphar.2020.173211", "ArticleIdList": ["10.1016/j.ejphar.2020.173211", "32464194"]}, {"Citation": "Deng M., Liu B., Song H., Yu R., Zou D., Chen Y., et al. (2020). \u03b2-Elemene inhibits the metastasis of multidrug-resistant gastric cancer cells through miR-1323/Cbl-b/EGFR pathway. Phytomedicine 69, 153184. 10.1016/j.phymed.2020.153184", "ArticleIdList": ["10.1016/j.phymed.2020.153184", "32199253"]}, {"Citation": "Deng M., Zhang Y., Liu B., Chen Y., Song H., Yu R., et al. (2019). \u03b2-Elemene inhibits peritoneal metastasis of gastric cancer cells by modulating FAK/Claudin-1 signaling. Phytother. Res. 33 (9), 2448\u20132456. 10.1002/ptr.6436", "ArticleIdList": ["10.1002/ptr.6436", "31342604"]}, {"Citation": "Deng X., Zhao J., Qu L., Duan Z., Fu R., Zhu C., et al. (2020). Ginsenoside Rh4 suppresses aerobic glycolysis and the expression of PD-L1 via targeting AKT in esophageal cancer. Biochem. Pharmacol. 178, 114038. 10.1016/j.bcp.2020.114038", "ArticleIdList": ["10.1016/j.bcp.2020.114038", "32422139"]}, {"Citation": "Diener C., Keller A., Meese E. (2022). Emerging concepts of miRNA therapeutics: From cells to clinic. Trends Genet. 38 (6), 613\u2013626. 10.1016/j.tig.2022.02.006", "ArticleIdList": ["10.1016/j.tig.2022.02.006", "35303998"]}, {"Citation": "Ding P., Guo Y., Wang C., Chen J., Guo C., Liu H., et al. (2022). A network pharmacology approach for uncovering the antitumor effects and potential mechanisms of the Sijunzi decoction for the treatment of gastric cancer. Evid. Based. Complement. Altern. Med. 2022, 9364313. 10.1155/2022/9364313", "ArticleIdList": ["10.1155/2022/9364313", "PMC9019414", "35463069"]}, {"Citation": "Ditty M. J., Ezhilarasan D. (2021). \u03b2-sitosterol induces reactive oxygen species-mediated apoptosis in human hepatocellular carcinoma cell line. Avicenna J. Phytomed. 11 (6), 541\u2013550. 10.22038/AJP.2021.17746", "ArticleIdList": ["10.22038/AJP.2021.17746", "PMC8588954", "34804892"]}, {"Citation": "Fan X., Fu H., Xie N., Guo H., Fu T., Shan Y. (2021). Inhibition of JAK2/STAT3 signaling pathway by panaxadiol limits the progression of pancreatic cancer. Aging (Albany NY) 13 (19), 22830\u201322842. 10.18632/aging.203575", "ArticleIdList": ["10.18632/aging.203575", "PMC8544303", "34623971"]}, {"Citation": "Feng L. S., Cheng J. B., Su W. Q., Li H. Z., Xiao T., Chen D. A., et al. (2022). Cinnamic acid hybrids as anticancer agents: A mini-review. Arch. Pharm. Weinh. 355, e2200052. 10.1002/ardp.202200052", "ArticleIdList": ["10.1002/ardp.202200052", "35419808"]}, {"Citation": "Feng S. L., Luo H. B., Cai L., Zhang J., Wang D., Chen Y. J., et al. (2020). Ginsenoside Rg5 overcomes chemotherapeutic multidrug resistance mediated by ABCB1 transporter: In vitro and in vivo study. J. Ginseng Res. 44 (2), 247\u2013257. 10.1016/j.jgr.2018.10.007", "ArticleIdList": ["10.1016/j.jgr.2018.10.007", "PMC7031741", "32148406"]}, {"Citation": "Feng S., Ning K., Shao P., Ren G., Sun P., Luo Z. (2018). Therapeutic effect of \u03b2-sitosterol and stigmasterol on acute colitis in mice. J. Chin. Cereals Oils Assoc. 33 (12), 80\u201386+94."}, {"Citation": "Gangwar V., Garg A., Lomore K., Korla K., Bhat S. S., Rao R. P., et al. (2021). Immunomodulatory effects of a concoction of natural bioactive compounds-mechanistic insights. Biomedicines 9 (11), 1522. 10.3390/biomedicines9111522", "ArticleIdList": ["10.3390/biomedicines9111522", "PMC8615223", "34829751"]}, {"Citation": "Gebert L., Macrae I. J. (2019). Regulation of microRNA function in animals. Nat. Rev. Mol. Cell Biol. 20 (1), 21\u201337. 10.1038/s41580-018-0045-7", "ArticleIdList": ["10.1038/s41580-018-0045-7", "PMC6546304", "30108335"]}, {"Citation": "Guo L., Song L., Wang Z., Zhao W., Mao W., Yin M. (2009). Panaxydol inhibits the proliferation and induces the differentiation of human hepatocarcinoma cell line HepG2. Chem. Biol. Interact. 181 (1), 138\u2013143. 10.1016/j.cbi.2009.04.015", "ArticleIdList": ["10.1016/j.cbi.2009.04.015", "19450571"]}, {"Citation": "Guo W., Du K., Luo S., Hu D. (2022). Recent advances of autophagy in non-small cell lung cancer: From basic mechanisms to clinical application. Front. Oncol. 12, 861959. 10.3389/fonc.2022.861959", "ArticleIdList": ["10.3389/fonc.2022.861959", "PMC9115384", "35600411"]}, {"Citation": "Ham J., Jeong D., Park S., Kim H. W., Kim H., Kim S. J. (2019). Ginsenoside Rg3 and Korean Red Ginseng extract epigenetically regulate the tumor-related long noncoding RNAs RFX3-AS1 and STXBP5-AS1. J. Ginseng Res. 43 (4), 625\u2013634. 10.1016/j.jgr.2019.02.004", "ArticleIdList": ["10.1016/j.jgr.2019.02.004", "PMC6823807", "31700260"]}, {"Citation": "Hamilton P. T., Anholt B. R., Nelson B. H. (2022). Tumour immunotherapy: Lessons from predator-prey theory. Nat. Rev. Immunol. 1, 1. 10.1038/s41577-022-00719-y", "ArticleIdList": ["10.1038/s41577-022-00719-y", "35513493"]}, {"Citation": "Han B., Jiang Y., Zhang C., Zhou Y., Wang Y. (2012). Effect of 20(S)-ginsenoside Rg3 on the proliferation and apoptosis of colon cancer stem cells. Chin. J. Gerontology 32 (20), 4431\u20134433."}, {"Citation": "Han Q., Han L., Tie F., Wang Z., Ma C., Li J., et al. (2020). (20S)-Protopanaxadiol ginsenosides induced cytotoxicity via blockade of autophagic flux in HGC-27 cells. Chem. Biodivers. 17 (7), e2000187. 10.1002/cbdv.202000187", "ArticleIdList": ["10.1002/cbdv.202000187", "32384197"]}, {"Citation": "Han S., Jeong A. J., Yang H., Bin K. K., Lee H., Yi E. H., et al. (2016). Ginsenoside 20(S)-Rh2 exerts anti-cancer activity through targeting IL-6-induced JAK2/STAT3 pathway in human colorectal cancer cells. J. Ethnopharmacol. 194, 83\u201390. 10.1016/j.jep.2016.08.039", "ArticleIdList": ["10.1016/j.jep.2016.08.039", "27566200"]}, {"Citation": "He F., Yan Q., Fan L., Liu Y., Cui J., Wang J., et al. (2010). PBK/TOPK in the differential diagnosis of cholangiocarcinoma from hepatocellular carcinoma and its involvement in prognosis of human cholangiocarcinoma. Hum. Pathol. 41 (3), 415\u2013424. 10.1016/j.humpath.2009.05.016", "ArticleIdList": ["10.1016/j.humpath.2009.05.016", "19954816"]}, {"Citation": "He S., Tian S., He X., Le X., Ning Y., Chen J., et al. (2021). Multiple targeted self-emulsifying compound RGO reveals obvious anti-tumor potential in hepatocellular carcinoma. Mol. Ther. Oncolytics 22, 604\u2013616. 10.1016/j.omto.2021.08.008", "ArticleIdList": ["10.1016/j.omto.2021.08.008", "PMC8449031", "34589579"]}, {"Citation": "Hong C., Wang D., Liang J., Guo Y., Zhu Y., Xia J., et al. (2019). Novel ginsenoside-based multifunctional liposomal delivery system for combination therapy of gastric cancer. Theranostics 9 (15), 4437\u20134449. 10.7150/thno.34953", "ArticleIdList": ["10.7150/thno.34953", "PMC6599661", "31285771"]}, {"Citation": "Hong H., Baatar D., Hwang S. G. (2021). Anticancer activities of ginsenosides, the main active components of ginseng. Evid. Based. Complement. Altern. Med. 2021, 8858006. 10.1155/2021/8858006", "ArticleIdList": ["10.1155/2021/8858006", "PMC7875636", "33623532"]}, {"Citation": "Hong S., Cai W., Huang Z., Wang Y., Mi X., Huang Y., et al. (2020). Ginsenoside Rg3 enhances the anticancer effect of 5FU in colon cancer cells via the PI3K/AKT pathway. Oncol. Rep. 44 (4), 1333\u20131342. 10.3892/or.2020.7728", "ArticleIdList": ["10.3892/or.2020.7728", "PMC7448421", "32945504"]}, {"Citation": "Hu Q. (2018). Study of the regulation mechanism of CYP3A4 in HepG2 cells by ginsenoside triol based on nuclear receptor CAR. Nanchang: Nanchang University, 88."}, {"Citation": "Hu Q., Yao N., Wu J., Liu M., Liu F., Zhang H., et al. (2019). Constitutive androstane receptor weakens the induction of panaxytriol on CYP3A4 by repressing the activation of pregnane X receptor. Biochem. Pharmacol. 159, 32\u201339. 10.1016/j.bcp.2018.11.009", "ArticleIdList": ["10.1016/j.bcp.2018.11.009", "30414935"]}, {"Citation": "Hu S., Zhu Y., Xia X., Xu X., Chen F., Miao X., et al. (2019). Ginsenoside Rg3 prolongs survival of the orthotopic hepatocellular carcinoma model by inducing apoptosis and inhibiting angiogenesis. Anal. Cell. Pathol. 2019, 3815786. 10.1155/2019/3815786", "ArticleIdList": ["10.1155/2019/3815786", "PMC6732603", "31534898"]}, {"Citation": "Huang G., Khan I., Li X., Chen L., Leong W., Ho L. T., et al. (2017). Ginsenosides Rb3 and Rd reduce polyps formation while reinstate the dysbiotic gut microbiota and the intestinal microenvironment in Apc(Min/+) mice. Sci. Rep. 7 (1), 12552. 10.1038/s41598-017-12644-5", "ArticleIdList": ["10.1038/s41598-017-12644-5", "PMC5624945", "28970547"]}, {"Citation": "Huang J., Xu M., Fang Y. J., Lu M. S., Pan Z. Z., Huang W. Q., et al. (2017). Association between phytosterol intake and colorectal cancer risk: A case-control study. Br. J. Nutr. 117 (6), 839\u2013850. 10.1017/S0007114517000617", "ArticleIdList": ["10.1017/S0007114517000617", "28382872"]}, {"Citation": "Huang Y., Huang H., Han Z., Li W., Mai Z., Yuan R. (2019). Ginsenoside Rh2 inhibits angiogenesis in prostate cancer by targeting CNNM1. J. Nanosci. Nanotechnol. 19 (4), 1942\u20131950. 10.1166/jnn.2019.16404", "ArticleIdList": ["10.1166/jnn.2019.16404", "30486934"]}, {"Citation": "Ishay-Ronen D., Diepenbruck M., Kalathur R., Sugiyama N., Tiede S., Ivanek R., et al. (2019). Gain fat-lose metastasis: Converting invasive breast cancer cells into adipocytes inhibits cancer metastasis. Cancer Cell 35 (1), 17\u201332. e6. 10.1016/j.ccell.2018.12.002", "ArticleIdList": ["10.1016/j.ccell.2018.12.002", "30645973"]}, {"Citation": "Jang H. J., Han I. H., Kim Y. J., Yamabe N., Lee D., Hwang G. S., et al. (2014). Anticarcinogenic effects of products of heat-processed ginsenoside Re, a major constituent of ginseng berry, on human gastric cancer cells. J. Agric. Food Chem. 62 (13), 2830\u20132836. 10.1021/jf5000776", "ArticleIdList": ["10.1021/jf5000776", "24666263"]}, {"Citation": "Jiang H., Ma P., Duan Z., Liu Y., Shen S., Mi Y., et al. (2022). Ginsenoside Rh4 suppresses metastasis of gastric cancer via SIX1-dependent TGF-\u03b2/smad2/3 signaling pathway. Nutrients 14 (8), 1564. 10.3390/nu14081564", "ArticleIdList": ["10.3390/nu14081564", "PMC9032069", "35458126"]}, {"Citation": "Jiang J., Yuan Z., Sun Y., Bu Y., Li W., Fei Z. (2017). Ginsenoside Rg3 enhances the anti-proliferative activity of erlotinib in pancreatic cancer cell lines by downregulation of EGFR/PI3K/Akt signaling pathway. Biomed. Pharmacother. 96, 619\u2013625. 10.1016/j.biopha.2017.10.043", "ArticleIdList": ["10.1016/j.biopha.2017.10.043", "29035827"]}, {"Citation": "Jiang M., Zhu Y., Yu H. (2021). Ginsenoside 20(S)-Rg3 suppresses cell viability in esophageal squamous cell carcinoma via modulating miR-324-5p-targeted PSME3. Hum. Exp. Toxicol. 40 (11), 1974\u20131984. 10.1177/09603271211017311", "ArticleIdList": ["10.1177/09603271211017311", "34002647"]}, {"Citation": "Jung J., Lee J. H., Bae K. H., Jeong C. S. (2011). Anti-gastric actions of eugenol and cinnamic acid isolated from Cinnamomi Ramulus. Yakugaku Zasshi 131 (7), 1103\u20131110. 10.1248/yakushi.131.1103", "ArticleIdList": ["10.1248/yakushi.131.1103", "21720141"]}, {"Citation": "Kang K. A., Kim H. S., Kim D. H., Hyun J. W. (2013). The role of a ginseng saponin metabolite as a DNA methyltransferase inhibitor in colorectal cancer cells. Int. J. Oncol. 43 (1), 228\u2013236. 10.3892/ijo.2013.1931", "ArticleIdList": ["10.3892/ijo.2013.1931", "23652987"]}, {"Citation": "Kangsamaksin T., Chaithongyot S., Wootthichairangsan C., Hanchaina R., Tangshewinsirikul C., Svasti J. (2017). Lupeol and stigmasterol suppress tumor angiogenesis and inhibit cholangiocarcinoma growth in mice via downregulation of tumor necrosis factor-\u03b1. PLoS One 12 (12), e0189628. 10.1371/journal.pone.0189628", "ArticleIdList": ["10.1371/journal.pone.0189628", "PMC5726636", "29232409"]}, {"Citation": "Kawk H. W., Nam G. H., Kim M. J., Kim S. Y., Kim Y. M. (2021). Scaphium affine ethanol extract induces anoikis by regulating the EGFR/Akt pathway in HCT116 colorectal cancer cells. Front. Oncol. 11, 621346. 10.3389/fonc.2021.621346", "ArticleIdList": ["10.3389/fonc.2021.621346", "PMC8173041", "34094906"]}, {"Citation": "Khan Z., Nath N., Rauf A., Emran T. B., Mitra S., Islam F., et al. (2022). Multifunctional roles and pharmacological potential of beta-sitosterol: Emerging evidence toward clinical applications. Chem. Biol. Interact. 365, 110117. 10.1016/j.cbi.2022.110117", "ArticleIdList": ["10.1016/j.cbi.2022.110117", "35995256"]}, {"Citation": "Kim H. S., Lim J. M., Kim J. Y., Kim Y., Park S., Sohn J. (2016). Panaxydol, a component of Panax ginseng, induces apoptosis in cancer cells through EGFR activation and ER stress and inhibits tumor growth in mouse models. Int. J. Cancer. 138 (6), 1432\u20131441. 10.1002/ijc.29879", "ArticleIdList": ["10.1002/ijc.29879", "26421996"]}, {"Citation": "Kim J. W., Han S. W., Cho J. Y., Chung I. J., Kim J. G., Lee K. H., et al. (2020). Korean red ginseng for cancer-related fatigue in colorectal cancer patients with chemotherapy: A randomised phase III trial. Eur. J. Cancer. 130, 51\u201362. 10.1016/j.ejca.2020.02.018", "ArticleIdList": ["10.1016/j.ejca.2020.02.018", "32172198"]}, {"Citation": "Kim J. Y., Lee K. W., Kim S. H., Wee J. J., Kim Y. S., Lee H. J. (2002). Inhibitory effect of tumor cell proliferation and induction of G2/M cell cycle arrest by panaxytriol. Planta Med. 68 (2), 119\u2013122. 10.1055/s-2002-20240", "ArticleIdList": ["10.1055/s-2002-20240", "11859460"]}, {"Citation": "Kim J. Y., Yu S. J., Oh H. J., Lee J. Y., Kim Y., Sohn J. (2011). Panaxydol induces apoptosis through an increased intracellular calcium level, activation of JNK and p38 MAPK and NADPH oxidase-dependent generation of reactive oxygen species. Apoptosis 16 (4), 347\u2013358. 10.1007/s10495-010-0567-8", "ArticleIdList": ["10.1007/s10495-010-0567-8", "21190085"]}, {"Citation": "Kim Y. S., Li X. F., Kang K. H., Ryu B., Kim S. K. (2014). Stigmasterol isolated from marine microalgae Navicula incerta induces apoptosis in human hepatoma HepG2 cells. BMB Rep. 47 (8), 433\u2013438. 10.5483/bmbrep.2014.47.8.153", "ArticleIdList": ["10.5483/bmbrep.2014.47.8.153", "PMC4206714", "24286323"]}, {"Citation": "Lahiani M. H., Eassa S., Parnell C., Nima Z., Ghosh A., Biris A. S., et al. (2017). Carbon nanotubes as carriers of Panax ginseng metabolites and enhancers of ginsenosides Rb1 and Rg1 anti-cancer activity. Nanotechnology 28 (1), 015101. 10.1088/0957-4484/28/1/015101", "ArticleIdList": ["10.1088/0957-4484/28/1/015101", "27893436"]}, {"Citation": "Lamouille S., Xu J., Derynck R. (2014). Molecular mechanisms of epithelial-mesenchymal transition. Nat. Rev. Mol. Cell Biol. 15 (3), 178\u2013196. 10.1038/nrm3758", "ArticleIdList": ["10.1038/nrm3758", "PMC4240281", "24556840"]}, {"Citation": "Laumont C. M., Banville A. C., Gilardi M., Hollern D. P., Nelson B. H. (2022). Tumour-infiltrating B cells: Immunological mechanisms, clinical impact and therapeutic opportunities. Nat. Rev. Cancer 22, 414\u2013430. 10.1038/s41568-022-00466-1", "ArticleIdList": ["10.1038/s41568-022-00466-1", "PMC9678336", "35393541"]}, {"Citation": "Le C. F., Kailaivasan T. H., Chow S. C., Abdullah Z., Ling S. K., Fang C. M. (2017). Phytosterols isolated from Clinacanthus nutans induce immunosuppressive activity in murine cells. Int. Immunopharmacol. 44, 203\u2013210. 10.1016/j.intimp.2017.01.013", "ArticleIdList": ["10.1016/j.intimp.2017.01.013", "28119186"]}, {"Citation": "Lee D. Y., Park C. W., Lee S. J., Park H. R., Kim S. H., Son S. U., et al. (2019). Anti-cancer effects of Panax ginseng berry polysaccharides via activation of immune-related cells. Front. Pharmacol. 10, 1411. 10.3389/fphar.2019.01411", "ArticleIdList": ["10.3389/fphar.2019.01411", "PMC6988799", "32038228"]}, {"Citation": "Lee H., Lee S., Jeong D., Kim S. J. (2018). Ginsenoside Rh2 epigenetically regulates cell-mediated immune pathway to inhibit proliferation of MCF-7 breast cancer cells. J. Ginseng Res. 42 (4), 455\u2013462. 10.1016/j.jgr.2017.05.003", "ArticleIdList": ["10.1016/j.jgr.2017.05.003", "PMC6187096", "30337805"]}, {"Citation": "Lee S. Y., Kim G. T., Roh S. H., Song J. S., Kim H. J., Hong S. S., et al. (2009). Proteomic analysis of the anti-cancer effect of 20S-ginsenoside Rg3 in human colon cancer cell lines. Biosci. Biotechnol. Biochem. 73 (4), 811\u2013816. 10.1271/bbb.80637", "ArticleIdList": ["10.1271/bbb.80637", "19352032"]}, {"Citation": "Lee Y., Park A., Park Y. J., Jung H., Kim T. D., Noh J. Y., et al. (2022). Ginsenoside 20(R)-Rg3 enhances natural killer cell activity by increasing activating receptor expression through the MAPK/ERK signaling pathway. Int. Immunopharmacol. 107, 108618. 10.1016/j.intimp.2022.108618", "ArticleIdList": ["10.1016/j.intimp.2022.108618", "35219164"]}, {"Citation": "Li B., Qu G. (2019). Inhibition of the hypoxia-induced factor-1\u03b1 and vascular endothelial growth factor expression through ginsenoside Rg3 in human gastric cancer cells. J. Cancer Res. Ther. 15 (7), 1642\u20131646. 10.4103/jcrt.JCRT_77_17", "ArticleIdList": ["10.4103/jcrt.JCRT_77_17", "31939450"]}, {"Citation": "Li G G., Xie H., Cao X., Ma C., Li Y., Chen L. (2022). Ginsenoside Rg1 exerts antiapoptotic effects on nonalcoholic fatty liver cells by downregulating the expression of SGPL1. Mol. Med. Rep. 25 (5), 178. 10.3892/mmr.2022.12694", "ArticleIdList": ["10.3892/mmr.2022.12694", "PMC8972265", "35322862"]}, {"Citation": "Li H., Gu L., Zhong Y., Chen Y., Zhang L., Zhang A. R., et al. (2016a). Administration of polysaccharide from Panax notoginseng prolonged the survival of H22 tumor-bearing mice. Onco. Targets. Ther. 9, 3433\u20133441. 10.2147/OTT.S79427", "ArticleIdList": ["10.2147/OTT.S79427", "PMC4907734", "27354815"]}, {"Citation": "Li H., Zhang J., Zhang H., Tao Z., Yang J., Kang T. (2016b). Enzymatic digestion of total ginseng protein and determination of amino acid content. Mod. Chin. Med. 18 (01), 72\u201375+81."}, {"Citation": "Li J., Huang Q., Yao Y., Ji P., Mingyao E., Chen J., et al. (2022a). Biotransformation, pharmacokinetics, and pharmacological activities of ginsenoside Rd against multiple diseases. Front. Pharmacol. 13, 909363. 10.3389/fphar.2022.909363", "ArticleIdList": ["10.3389/fphar.2022.909363", "PMC9343777", "35928281"]}, {"Citation": "Li J., Qi Y. (2019). Ginsenoside Rg3 inhibits cell growth, migration and invasion in Caco-2 cells by downregulation of lncRNA CCAT1. Exp. Mol. Pathol. 106, 131\u2013138. 10.1016/j.yexmp.2019.01.003", "ArticleIdList": ["10.1016/j.yexmp.2019.01.003", "30633886"]}, {"Citation": "Li J., Zhao Y., Xu N., Xing S., Shu Z., Pang B., et al. (2022b). Pharmacological effects of ginseng protein. Special Wild Econ. Animal Plant Res. 44 (02), 121\u2013126."}, {"Citation": "Li M., Tang D., Yang T., Qian D., Xu R. (2021a). Apoptosis triggering, an important way for natural products from herbal medicines to treat pancreatic cancers. Front. Pharmacol. 12, 796300. 10.3389/fphar.2021.796300", "ArticleIdList": ["10.3389/fphar.2021.796300", "PMC8863938", "35222011"]}, {"Citation": "Li M., Wang X., Wang Y., Bao S., Chang Q., Liu L., et al. (2021b). Strategies for remodeling the tumor microenvironment using active ingredients of ginseng-A promising approach for cancer therapy. Front. Pharmacol. 12, 797634. 10.3389/fphar.2021.797634", "ArticleIdList": ["10.3389/fphar.2021.797634", "PMC8727883", "35002732"]}, {"Citation": "Li M., Zhang D., Cheng J., Liang J., Yu F. (2019). Retracted: Ginsenoside Rh2 inhibits proliferation but promotes apoptosis and autophagy by down-regulating microRNA-638 in human retinoblastoma cells. Exp. Mol. Pathol. 108, 17\u201323. 10.1016/j.yexmp.2019.03.004", "ArticleIdList": ["10.1016/j.yexmp.2019.03.004", "30853612"]}, {"Citation": "Li Q., Jiang C., Zhang L., Qiu W., Meng X. (2012). Apoptosis of human hepatocellular carcinoma cells SMMC-7721 induced by \u03b2-sitosterol and dousterol. Lishizhen Med. Materia Medica Res. 23 (05), 1173\u20131175."}, {"Citation": "Li Q., Li B., Dong C., Wang Y., Li Q. (2017). 20(S)-Ginsenoside Rh2 suppresses proliferation and migration of hepatocellular carcinoma cells by targeting EZH2 to regulate CDKN2A-2B gene cluster transcription. Eur. J. Pharmacol. 815, 173\u2013180. 10.1016/j.ejphar.2017.09.023", "ArticleIdList": ["10.1016/j.ejphar.2017.09.023", "28928088"]}, {"Citation": "Li W. F., Chen L. R., Gong X. J., Li Z. N., Li K. K. (2013). Synthesis of esters of ginsenoside metabolite M1 and their cytotoxicity on MGC80-3 cells. Molecules 18 (4), 3689\u20133702. 10.3390/molecules18043689", "ArticleIdList": ["10.3390/molecules18043689", "PMC6270463", "23529029"]}, {"Citation": "Li X., Lin Z., Zhang B., Guo L., Liu S., Li H., et al. (2016). \u03b2-elemene sensitizes hepatocellular carcinoma cells to oxaliplatin by preventing oxaliplatin-induced degradation of copper transporter 1. Sci. Rep. 6, 21010. 10.1038/srep21010", "ArticleIdList": ["10.1038/srep21010", "PMC4751482", "26867799"]}, {"Citation": "Li X., Tsauo J., Geng C., Zhao H., Lei X., Li X. (2018). Ginsenoside Rg3 decreases NHE1 expression via inhibiting EGF-EGFR-ERK1/2-HIF-1 alpha pathway in hepatocellular carcinoma: A novel antitumor mechanism. Am. J. Chin. Med. 46 (8), 1915\u20131931. 10.1142/S0192415X18500969", "ArticleIdList": ["10.1142/S0192415X18500969", "30525897"]}, {"Citation": "Li Y Y., He F., Zhang Y., Pan Z. (2022). Apatinib and ginsenoside-Rb1 synergetically control the growth of hypopharyngeal carcinoma cells. Dis. Markers 2022, 3833489. 10.1155/2022/3833489", "ArticleIdList": ["10.1155/2022/3833489", "PMC8776476", "35069931"]}, {"Citation": "Liang Q., Yang J., He J., Chen X., Zhang H., Jia M., et al. (2020). Stigmasterol alleviates cerebral ischemia/reperfusion injury by attenuating inflammation and improving antioxidant defenses in rats. Biosci. Rep. 40 (4), BSR20192133. 10.1042/BSR20192133", "ArticleIdList": ["10.1042/BSR20192133", "PMC7160377", "32149332"]}, {"Citation": "Lin H., Piao B., Li S. (2002). Summary of phase \u2161 clinical trial of shenyi capsule in the treatment of lung cancer. Chin. J. Clin. Oncol. 1 (04), 52\u201355."}, {"Citation": "Ling S., Li J., Shan Q., Dai H., Lu D., Wen X., et al. (2017). USP22 mediates the multidrug resistance of hepatocellular carcinoma via the SIRT1/AKT/MRP1 signaling pathway. Mol. Oncol. 11 (6), 682\u2013695. 10.1002/1878-0261.12067", "ArticleIdList": ["10.1002/1878-0261.12067", "PMC5467492", "28417539"]}, {"Citation": "Liu G. W., Liu Y. H., Jiang G. S., Ren W. D. (2018). The reversal effect of Ginsenoside Rh2 on drug resistance in human colorectal carcinoma cells and its mechanism. Hum. Cell. 31 (3), 189\u2013198. 10.1007/s13577-017-0189-3", "ArticleIdList": ["10.1007/s13577-017-0189-3", "29582366"]}, {"Citation": "Liu G., Zhang J., Sun F., Ma J., Qi X. (2022). Ginsenoside Rg2 attenuated trastuzumab-induced cardiotoxicity in rats. Biomed. Res. Int. 2022, 8866660. 10.1155/2022/8866660", "ArticleIdList": ["10.1155/2022/8866660", "PMC8769853", "35071601"]}, {"Citation": "Liu H., Zhao J., Fu R., Zhu C., Fan D. (2019). The ginsenoside Rk3 exerts anti-esophageal cancer activity in vitro and in vivo by mediating apoptosis and autophagy through regulation of the PI3K/Akt/mTOR pathway. PLoS One 14 (5), e0216759. 10.1371/journal.pone.0216759", "ArticleIdList": ["10.1371/journal.pone.0216759", "PMC6519821", "31091245"]}, {"Citation": "Liu J., Wang Y., Yu Z., Lv G., Huang X., Lin H., et al. (2022). Functional mechanism of ginsenoside compound K on tumor growth and metastasis. Integr. Cancer Ther. 21, 1. 10.1177/15347354221101203", "ArticleIdList": ["10.1177/15347354221101203", "PMC9152193", "35615883"]}, {"Citation": "Liu S., Chen M., Li P., Wu Y., Chang C., Qiu Y., et al. (2015). Ginsenoside rh2 inhibits cancer stem-like cells in skin squamous cell carcinoma. Cell. Physiol. biochem. 36 (2), 499\u2013508. 10.1159/000430115", "ArticleIdList": ["10.1159/000430115", "25966742"]}, {"Citation": "Liu T., Duo L., Duan P. (2018). Ginsenoside Rg3 sensitizes colorectal cancer to radiotherapy through downregulation of proliferative and angiogenic biomarkers. Evid. Based. Complement. Altern. Med. 2018, 1580427. 10.1155/2018/1580427", "ArticleIdList": ["10.1155/2018/1580427", "PMC5878898", "29743919"]}, {"Citation": "Liu Y., Fan D. (2019). Ginsenoside Rg5 induces G2/M phase arrest, apoptosis and autophagy via regulating ROS-mediated MAPK pathways against human gastric cancer. Biochem. Pharmacol. 168, 285\u2013304. 10.1016/j.bcp.2019.07.008", "ArticleIdList": ["10.1016/j.bcp.2019.07.008", "31301277"]}, {"Citation": "Liu Y. P., Zheng C. C., Huang Y. N., He M. L., Xu W. W., Li B. (2021). Molecular mechanisms of chemo- and radiotherapy resistance and the potential implications for cancer treatment. MedComm 2 (3), 315\u2013340. 10.1002/mco2.55", "ArticleIdList": ["10.1002/mco2.55", "PMC8554658", "34766149"]}, {"Citation": "Liu Z., Liu T., Li W., Li J., Wang C., Zhang K. (2021). Insights into the antitumor mechanism of ginsenosides Rg3. Mol. Biol. Rep. 48 (3), 2639\u20132652. 10.1007/s11033-021-06187-2", "ArticleIdList": ["10.1007/s11033-021-06187-2", "33661439"]}, {"Citation": "Lu H., Yin H., Qu L., Ma X., Fu R., Fan D. (2022). Ginsenoside Rk1 regulates glutamine metabolism in hepatocellular carcinoma through inhibition of the ERK/c-Myc pathway. Food Funct. 13 (7), 3793\u20133811. 10.1039/d1fo03728e", "ArticleIdList": ["10.1039/d1fo03728e", "35316310"]}, {"Citation": "Lu M., Fei Z., Zhang G. (2018). Synergistic anticancer activity of 20(S)-Ginsenoside Rg3 and Sorafenib in hepatocellular carcinoma by modulating PTEN/Akt signaling pathway. Biomed. Pharmacother. 97, 1282\u20131288. 10.1016/j.biopha.2017.11.006", "ArticleIdList": ["10.1016/j.biopha.2017.11.006", "29156516"]}, {"Citation": "Lu S., Zhang Y., Li H., Zhang J., Ci Y., Han M. (2020). Ginsenoside Rb1 can ameliorate the key inflammatory cytokines TNF-alpha and IL-6 in a cancer cachexia mouse model. BMC Complement. Med. Ther. 20 (1), 11. 10.1186/s12906-019-2797-9", "ArticleIdList": ["10.1186/s12906-019-2797-9", "PMC7076885", "32020864"]}, {"Citation": "Luo L., Shi Y., Jiang Y., Zhan J., Tan L., Chen N. (2017). Advances in the study of active ingredients and their mechanisms of anti-tumor effects of ginseng. Chin. Traditional Herb. Drugs 48 (03), 582\u2013596."}, {"Citation": "Luo X., Wang H., Ji D. (2021). Carbon nanotubes (CNT)-loaded ginsenosides Rb3 suppresses the PD-1/PD-L1 pathway in triple-negative breast cancer. Aging (Albany NY) 13 (13), 17177\u201317189. 10.18632/aging.203131", "ArticleIdList": ["10.18632/aging.203131", "PMC8312428", "34111025"]}, {"Citation": "Ma H., Yu Y., Wang M., Li Z., Xu H., Tian C., et al. (2019). Correlation between microbes and colorectal cancer: Tumor apoptosis is induced by sitosterols through promoting gut microbiota to produce short-chain fatty acids. Apoptosis 24 (1-2), 168\u2013183. 10.1007/s10495-018-1500-9", "ArticleIdList": ["10.1007/s10495-018-1500-9", "30506375"]}, {"Citation": "Ma J., Gao G., Lu H., Fang D., Li L., Wei G., et al. (2019). Reversal effect of ginsenoside Rh2 on oxaliplatin-resistant colon cancer cells and its mechanism. Exp. Ther. Med. 18 (1), 630\u2013636. 10.3892/etm.2019.7604", "ArticleIdList": ["10.3892/etm.2019.7604", "PMC6566025", "31258699"]}, {"Citation": "Ma L., Miao D., Lee J. J., Li T., Chen Y., Su G., et al. (2021). Synthesis and biological evaluation of heterocyclic ring-fused dammarane-type ginsenoside derivatives as potential anti-tumor agents. Bioorg. Chem. 116, 105365. 10.1016/j.bioorg.2021.105365", "ArticleIdList": ["10.1016/j.bioorg.2021.105365", "34563998"]}, {"Citation": "Mahmoud A. A., El-Sayed W. M. (2019). The anti-proliferative activity of anisosciadone: A new guaiane sesquiterpene from anisosciadium lanatum. Anticancer. Agents Med. Chem. 19 (9), 1114\u20131119. 10.2174/1871520619666190308112732", "ArticleIdList": ["10.2174/1871520619666190308112732", "30848216"]}, {"Citation": "Mao Q., Zhang P. H., Yang J., Xu J. D., Kong M., Shen H., et al. (2016). iTRAQ-based proteomic analysis of ginsenoside F2 on human gastric carcinoma cells SGC7901. Evid. Based. Complement. Altern. Med. 2016, 2635483. 10.1155/2016/2635483", "ArticleIdList": ["10.1155/2016/2635483", "PMC5088344", "27829861"]}, {"Citation": "Mizushima N., Levine B., Cuervo A. M., Klionsky D. J. (2008). Autophagy fights disease through cellular self-digestion. Nature 451 (7182), 1069\u20131075. 10.1038/nature06639", "ArticleIdList": ["10.1038/nature06639", "PMC2670399", "18305538"]}, {"Citation": "Mylod E., Lysaght J., Conroy M. J. (2022). Natural killer cell therapy: A new frontier for obesity-associated cancer. Cancer Lett. 535, 215620. 10.1016/j.canlet.2022.215620", "ArticleIdList": ["10.1016/j.canlet.2022.215620", "35283210"]}, {"Citation": "Nakhjavani M., Smith E., Townsend A. R., Price T. J., Hardingham J. E. (2020). Anti-angiogenic properties of ginsenoside Rg3. Molecules 25 (21), E4905. 10.3390/molecules25214905", "ArticleIdList": ["10.3390/molecules25214905", "PMC7660320", "33113992"]}, {"Citation": "Nisha R., Kumar P., Gautam A. K., Bera H., Bhattacharya B., Parashar P., et al. (2021). Assessments of in vitro and in vivo antineoplastic potentials of beta-sitosterol-loaded PEGylated niosomes against hepatocellular carcinoma. J. Liposome Res. 31 (3), 304\u2013315. 10.1080/08982104.2020.1820520", "ArticleIdList": ["10.1080/08982104.2020.1820520", "32901571"]}, {"Citation": "Pak J. N., Jung J. H., Park J. E., Hwang J., Lee H. J., Shim B. S., et al. (2020). p53 dependentLGR5 inhibition and caspase 3 activation are critically involved in apoptotic effect of compound K and its combination therapy potential inHCT116 cells. Phytother. Res. 34 (10), 2745\u20132755. 10.1002/ptr.6717", "ArticleIdList": ["10.1002/ptr.6717", "32403193"]}, {"Citation": "Pandey P., Bajpai P., Siddiqui M. H., Sayyed U., Tiwari R., Shekh R., et al. (2019). Elucidation of the chemopreventive role of stigmasterol against Jab1 in gall bladder carcinoma. Endocr. Metab. Immune Disord. Drug Targets 19 (6), 826\u2013837. 10.2174/1871530319666190206124120", "ArticleIdList": ["10.2174/1871530319666190206124120", "30727937"]}, {"Citation": "Pandith H., Zhang X., Thongpraditchote S., Wongkrajang Y., Gritsanapan W., Baek S. J. (2013). Effect of Siam weed extract and its bioactive component scutellarein tetramethyl ether on anti-inflammatory activity through NF-\u03baB pathway. J. Ethnopharmacol. 147 (2), 434\u2013441. 10.1016/j.jep.2013.03.033", "ArticleIdList": ["10.1016/j.jep.2013.03.033", "23535395"]}, {"Citation": "Paramasivam A., Priyadharsini J. V. (2021). RNA N6-methyladenosine: A new player in autophagy-mediated anti-cancer drug resistance. Br. J. Cancer 124 (10), 1621\u20131622. 10.1038/s41416-021-01314-z", "ArticleIdList": ["10.1038/s41416-021-01314-z", "PMC8110764", "33723389"]}, {"Citation": "Phi L., Wijaya Y. T., Sari I. N., Kim K. S., Yang Y. G., Lee M. W., et al. (2019). 20(R)-Ginsenoside Rg3 influences cancer stem cell properties and the epithelial-mesenchymal transition in colorectal cancer via the SNAIL signaling Axis. Onco. Targets. Ther. 12, 10885\u201310895. 10.2147/OTT.S219063", "ArticleIdList": ["10.2147/OTT.S219063", "PMC6912006", "31849492"]}, {"Citation": "Phi L., Wijaya Y. T., Sari I. N., Yang Y. G., Lee Y. K., Kwon H. Y. (2018). The anti-metastatic effect of ginsenoside Rb2 in colorectal cancer in an EGFR/SOX2-dependent manner. Cancer Med. 7 (11), 5621\u20135631. 10.1002/cam4.1800", "ArticleIdList": ["10.1002/cam4.1800", "PMC6246932", "30264477"]}, {"Citation": "Pu Z., Ge F., Wang Y., Jiang Z., Zhu S., Qin S., et al. (2021). Ginsenoside-Rg3 inhibits the proliferation and invasion of hepatoma carcinoma cells via regulating long non-coding RNA HOX antisense intergenic. Bioengineered 12 (1), 2398\u20132409. 10.1080/21655979.2021.1932211", "ArticleIdList": ["10.1080/21655979.2021.1932211", "PMC8806740", "34130594"]}, {"Citation": "Qi Z., Chen L., Li Z., Shao Z., Qi Y., Gao K., et al. (2019). Immunomodulatory effects of (24r)-pseudo-ginsenoside HQ and (24S)-Pseudo-Ginsenoside HQ on cyclophosphamide-induced immunosuppression and their anti-tumor effects study. Int. J. Mol. Sci. 20 (4), E836. 10.3390/ijms20040836", "ArticleIdList": ["10.3390/ijms20040836", "PMC6413033", "30769948"]}, {"Citation": "Qian J., Li J., Jia J. G., Jin X., Yu D. J., Guo C. X., et al. (2016). Ginsenoside-Rh2 inhibits proliferation and induces apoptosis of human gastric cancer SGC-7901 side population cells. Asian pac. J. Cancer Prev. 17 (4), 1817\u20131821. 10.7314/apjcp.2016.17.4.1817", "ArticleIdList": ["10.7314/apjcp.2016.17.4.1817", "27221858"]}, {"Citation": "Qiu R., Qian F., Wang X., Li H., Wang L. (2019). Targeted delivery of 20(S)-ginsenoside Rg3-based polypeptide nanoparticles to treat colon cancer. Biomed. Microdevices 21 (1), 18. 10.1007/s10544-019-0374-0", "ArticleIdList": ["10.1007/s10544-019-0374-0", "30783757"]}, {"Citation": "Qu L., Ma X., Fan D. (2021). Ginsenoside Rk3 suppresses hepatocellular carcinoma development through targeting the gut-liver Axis. J. Agric. Food Chem. 69 (35), 10121\u201310137. 10.1021/acs.jafc.1c03279", "ArticleIdList": ["10.1021/acs.jafc.1c03279", "34415764"]}, {"Citation": "Qu Y., Li S., Zhang S., Gao J., Lin Z., Yin Y., et al. (2021). A network pharmacological study on the prevention of postoperative recurrence and metastasis of colorectal cancer with Radix Codonopsis pilosulae and Radix et Rhizoma alba. Anti-Tumor Pharm. 11 (06), 707\u2013719."}, {"Citation": "Raj R. K., D E., S R. (2020). \u03b2-Sitosterol-assisted silver nanoparticles activates Nrf2 and triggers mitochondrial apoptosis via oxidative stress in human hepatocellular cancer cell line. J. Biomed. Mat. Res. A 108 (9), 1899\u20131908. 10.1002/jbm.a.36953", "ArticleIdList": ["10.1002/jbm.a.36953", "32319188"]}, {"Citation": "Raj S., Jayaraj R., Kodiveri M. G. (2022). Chemical profiling and evaluation of antioxidant and anticancer potential of tuber crop Amorphophallus commutatus var. wayanadensis. Plant Foods Hum. Nutr. 77 (1), 68\u201376. 10.1007/s11130-021-00942-3", "ArticleIdList": ["10.1007/s11130-021-00942-3", "34977995"]}, {"Citation": "Rajavel T., Packiyaraj P., Suryanarayanan V., Singh S. K., Ruckmani K., Pandima D. K. (2018). \u03b2-Sitosterol targets Trx/Trx1 reductase to induce apoptosis in A549 cells via ROS mediated mitochondrial dysregulation and p53 activation. Sci. Rep. 8 (1), 2071. 10.1038/s41598-018-20311-6", "ArticleIdList": ["10.1038/s41598-018-20311-6", "PMC5794769", "29391428"]}, {"Citation": "Rather R. A., Bhagat M. (2020). Quercetin as an innovative therapeutic tool for cancer chemoprevention: Molecular mechanisms and implications in human health. Cancer Med. 9 (24), 9181\u20139192. 10.1002/cam4.1411", "ArticleIdList": ["10.1002/cam4.1411", "PMC7774748", "31568659"]}, {"Citation": "Ren Y. (2019). Extraction of ginseng protein and its antitumor effect on breast cancer MCF-7 cells. Changchun: Changchun University of Chinese Medicine, 59."}, {"Citation": "Ren Z., Chen X., Hong L., Zhao X., Cui G., Li A., et al. (2020). Nanoparticle conjugation of ginsenoside Rg3 inhibits hepatocellular carcinoma development and metastasis. Small 16 (2), e1905233. 10.1002/smll.201905233", "ArticleIdList": ["10.1002/smll.201905233", "31814271"]}, {"Citation": "Riabov V., Gudima A., Wang N., Mickley A., Orekhov A., Kzhyshkowska J. (2014). Role of tumor associated macrophages in tumor angiogenesis and lymphangiogenesis. Front. Physiol. 5, 75. 10.3389/fphys.2014.00075", "ArticleIdList": ["10.3389/fphys.2014.00075", "PMC3942647", "24634660"]}, {"Citation": "Roy R. K., Yadav R., Sharma U., Wasson M. K., Sharma A., Tanwar P., et al. (2022). Impact of noncoding RNAs on cancer directed immune therapies: Now then and forever. Int. J. Cancer 151, 981\u2013992. 10.1002/ijc.34060", "ArticleIdList": ["10.1002/ijc.34060", "35489027"]}, {"Citation": "Ryan K. M. (2011). p53 and autophagy in cancer: guardian of the genome meets guardian of the proteome. Eur. J. Cancer. 47 (1), 44\u201350. 10.1016/j.ejca.2010.10.020", "ArticleIdList": ["10.1016/j.ejca.2010.10.020", "21112207"]}, {"Citation": "Sabeva N. S., Mcphaul C. M., Li X., Cory T. J., Feola D. J., Graf G. A. (2011). Phytosterols differentially influence ABC transporter expression, cholesterol efflux and inflammatory cytokine secretion in macrophage foam cells. J. Nutr. Biochem. 22 (8), 777\u2013783. 10.1016/j.jnutbio.2010.07.002", "ArticleIdList": ["10.1016/j.jnutbio.2010.07.002", "PMC3075387", "21111593"]}, {"Citation": "Salehi B., Quispe C., Sharifi-Rad J., Cruz-Martins N., Nigam M., Mishra A. P., et al. (2020). Phytosterols: From preclinical evidence to potential clinical applications. Front. Pharmacol. 11, 599959. 10.3389/fphar.2020.599959", "ArticleIdList": ["10.3389/fphar.2020.599959", "PMC7841260", "33519459"]}, {"Citation": "Shang H., Li L., Ma L., Tian Y., Jia H., Zhang T., et al. (2020). Design and synthesis of molecular hybrids of Sophora alkaloids and cinnamic acids as potential antitumor agents. Molecules 25 (5), E1168. 10.3390/molecules25051168", "ArticleIdList": ["10.3390/molecules25051168", "PMC7179170", "32150948"]}, {"Citation": "Sharmila R., Sindhu G. (2017). Modulation of angiogenesis, proliferative response and apoptosis by beta-sitosterol in rat model of renal carcinogenesis. Indian J. Clin. biochem. 32 (2), 142\u2013152. 10.1007/s12291-016-0583-8", "ArticleIdList": ["10.1007/s12291-016-0583-8", "PMC5382068", "28428688"]}, {"Citation": "Shathviha P. C., Ezhilarasan D., Rajeshkumar S., Selvaraj J. (2021). \u03b2-Sitosterol mediated silver nanoparticles induce cytotoxicity in human colon cancer HT-29 cells. Avicenna J. Med. Biotechnol. 13 (1), 42\u201346. 10.18502/ajmb.v13i1.4577", "ArticleIdList": ["10.18502/ajmb.v13i1.4577", "PMC7903430", "33680372"]}, {"Citation": "Shen M., Hu Y., Yang Y., Wang L., Yang X., Wang B., et al. (2019). Betulinic acid induces ROS-dependent apoptosis and S-phase Arrest by inhibiting the NF-\u03baB pathway in human multiple myeloma. Oxid. Med. Cell. Longev. 2019, 5083158. 10.1155/2019/5083158", "ArticleIdList": ["10.1155/2019/5083158", "PMC6590575", "31281581"]}, {"Citation": "Shi Q., Shi X., Zuo G., Xiong W., Li H., Guo P., et al. (2016). Anticancer effect of 20(S)-ginsenoside Rh2 on HepG2 liver carcinoma cells: Activating GSK-3\u03b2 and degrading \u03b2-catenin. Oncol. Rep. 36 (4), 2059\u20132070. 10.3892/or.2016.5033", "ArticleIdList": ["10.3892/or.2016.5033", "27573179"]}, {"Citation": "Shi Z. Y., Zeng J. Z., Wong A. (2019). Chemical structures and pharmacological profiles of ginseng saponins. Molecules 24 (13), E2443. 10.3390/molecules24132443", "ArticleIdList": ["10.3390/molecules24132443", "PMC6651355", "31277214"]}, {"Citation": "Shin E. J., Choi H. K., Sung M. J., Park J. H., Chung M. Y., Chung S., et al. (2018). Anti-tumour effects of beta-sitosterol are mediated by AMPK/PTEN/HSP90 axis in AGS human gastric adenocarcinoma cells and xenograft mouse models. Biochem. Pharmacol. 152, 60\u201370. 10.1016/j.bcp.2018.03.010", "ArticleIdList": ["10.1016/j.bcp.2018.03.010", "29559312"]}, {"Citation": "Shin N., Lee H. J., Sim D. Y., Im E., Park J. E., Park W. Y., et al. (2021). Apoptotic effect of compound K in hepatocellular carcinoma cells via inhibition of glycolysis and Akt/mTOR/c-Myc signaling. Phytother. Res. 35 (7), 3812\u20133820. 10.1002/ptr.7087", "ArticleIdList": ["10.1002/ptr.7087", "33856720"]}, {"Citation": "Srijiwangsa P., Ponnikorn S., Na-Bangchang K. (2018). Effect of beta-Eudesmol on NQO1 suppression-enhanced sensitivity of cholangiocarcinoma cells to chemotherapeutic agents. BMC Pharmacol. Toxicol. 19 (1), 32. 10.1186/s40360-018-0223-4", "ArticleIdList": ["10.1186/s40360-018-0223-4", "PMC6006851", "29914576"]}, {"Citation": "Su J., Zhang F., Li X., Liu Z. (2019). Osthole promotes the suppressive effects of cisplatin on NRF2 expression to prevent drug-resistant cervical cancer progression. Biochem. Biophys. Res. Commun. 514 (2), 510\u2013517. 10.1016/j.bbrc.2019.04.021", "ArticleIdList": ["10.1016/j.bbrc.2019.04.021", "31056260"]}, {"Citation": "Su P., Ahmad B., Zou K., Zou L. (2020). \u03b2-Elemene enhances the chemotherapeutic effect of 5-fluorouracil in triple-negative breast cancer via PI3K/AKT, RAF-MEK-ErK, and NF-\u03baB signaling pathways. Onco. Targets. Ther. 13, 5207\u20135222. 10.2147/OTT.S242820", "ArticleIdList": ["10.2147/OTT.S242820", "PMC7294576", "32606741"]}, {"Citation": "Subramanian S., Steer C. J. (2019). Special issue: MicroRNA regulation in health and disease. Genes (Basel) 10 (6), E457. 10.3390/genes10060457", "ArticleIdList": ["10.3390/genes10060457", "PMC6628077", "31208024"]}, {"Citation": "Sun D., Zou Y., Song L., Han S., Yang H., Chu D., et al. (2022). A cyclodextrin-based nanoformulation achieves co-delivery of ginsenoside Rg3 and quercetin for chemo-immunotherapy in colorectal cancer. Acta Pharm. Sin. B 12 (1), 378\u2013393. 10.1016/j.apsb.2021.06.005", "ArticleIdList": ["10.1016/j.apsb.2021.06.005", "PMC8799998", "35127393"]}, {"Citation": "Sun M. Y., Song Y. N., Zhang M., Zhang C. Y., Zhang L. J., Zhang H. (2019). Ginsenoside Rg3 inhibits the migration and invasion of liver cancer cells by increasing the protein expression of ARHGAP9. Oncol. Lett. 17 (1), 965\u2013973. 10.3892/ol.2018.9701", "ArticleIdList": ["10.3892/ol.2018.9701", "PMC6313058", "30655855"]}, {"Citation": "Tang J. (2021). Screening of effective components of the Chinese medicine Sanleng and its effect on the proliferation and apoptosis of gastric cancer MGC-803 cells. Hengyang: Nanhua University, 80."}, {"Citation": "Tang X., Liu J., Li L., Du R. (2012). Pharmacological effects of organic acids in traditional Chinese medicine and their application in cardiovascular diseases. Chin. J. Exp. Traditional Med. Formulae 18 (05), 243\u2013246."}, {"Citation": "Tang Y. C., Zhang Y., Zhou J., Zhi Q., Wu M. Y., Gong F. R., et al. (2018). Ginsenoside Rg3 targets cancer stem cells and tumor angiogenesis to inhibit colorectal cancer progression in vivo . Int. J. Oncol. 52 (1), 127\u2013138. 10.3892/ijo.2017.4183", "ArticleIdList": ["10.3892/ijo.2017.4183", "PMC5743384", "29115601"]}, {"Citation": "Tian Y. Z., Liu Y. P., Tian S. C., Ge S. Y., Wu Y. J., Zhang B. L. (2020). Antitumor activity of ginsenoside Rd in gastric cancer via up-regulation of Caspase-3 and Caspase-9. Pharmazie 75 (4), 147\u2013150. 10.1691/ph.2020.9931", "ArticleIdList": ["10.1691/ph.2020.9931", "32295691"]}, {"Citation": "Tovey F. I. (2015). Role of dietary phospholipids and phytosterols in protection against peptic ulceration as shown by experiments on rats. World J. Gastroenterol. 21 (5), 1377\u20131384. 10.3748/wjg.v21.i5.1377", "ArticleIdList": ["10.3748/wjg.v21.i5.1377", "PMC4316080", "25663757"]}, {"Citation": "Wang B., Xu Q., Zhou C., Lin Y. (2021). Liposomes co-loaded with ursolic acid and ginsenoside Rg3 in the treatment of hepatocellular carcinoma. Acta Biochim. Pol. 68 (4), 711\u2013715. 10.18388/abp.2020_5608", "ArticleIdList": ["10.18388/abp.2020_5608", "34730903"]}, {"Citation": "Wang C. Z., Hou L., Wan J. Y., Yao H., Yuan J., Zeng J., et al. (2020). Ginseng berry polysaccharides on inflammation-associated colon cancer: Inhibiting T-cell differentiation, promoting apoptosis, and enhancing the effects of 5-fluorouracil. J. Ginseng Res. 44 (2), 282\u2013290. 10.1016/j.jgr.2018.12.010", "ArticleIdList": ["10.1016/j.jgr.2018.12.010", "PMC7031751", "32148410"]}, {"Citation": "Wang G. Y., Zhang L., Geng Y. D., Wang B., Feng X. J., Chen Z. L., et al. (2022). \u03b2-Elemene induces apoptosis and autophagy in colorectal cancer cells through regulating the ROS/AMPK/mTOR pathway. Chin. J. Nat. Med. 20 (1), 9\u201321. 10.1016/S1875-5364(21)60118-8", "ArticleIdList": ["10.1016/S1875-5364(21)60118-8", "35101253"]}, {"Citation": "Wang J., Xu C., Chen Y., Shao L., Li T., Fan X., et al. (2021). \u03b2-elemene enhances the antitumor activity of erlotinib by inducing apoptosis through AMPK and MAPK pathways in TKI-resistant H1975 lung cancer cells. J. Cancer. 12 (8), 2285\u20132294. 10.7150/jca.53382", "ArticleIdList": ["10.7150/jca.53382", "PMC7974887", "33758606"]}, {"Citation": "Wang W., Zhong W., Yuan J., Yan C., Hu S., Tong Y., et al. (2015). Involvement of Wnt/\u03b2-catenin signaling in the mesenchymal stem cells promote metastatic growth and chemoresistance of cholangiocarcinoma. Oncotarget 6 (39), 42276\u201342289. 10.18632/oncotarget.5514", "ArticleIdList": ["10.18632/oncotarget.5514", "PMC4747224", "26474277"]}, {"Citation": "Wang X., He R., Geng L., Yuan J., Fan H. (2022). Ginsenoside Rg3 alleviates cisplatin resistance of gastric cancer cells through inhibiting SOX2 and the PI3K/Akt/mTOR signaling Axis by up-regulating miR-429. Front. Genet. 13, 823182. 10.3389/fgene.2022.823182", "ArticleIdList": ["10.3389/fgene.2022.823182", "PMC8927288", "35309116"]}, {"Citation": "Wang X., Sun Y. Y., Qu F. Z., Su G. Y., Zhao Y. Q. (2019). 4-XL-PPD, a novel ginsenoside derivative, as potential therapeutic agents for gastric cancer shows anti-cancer activity via inducing cell apoptosis medicated generation of reactive oxygen species and inhibiting migratory and invasive. Biomed. Pharmacother. 118, 108589. 10.1016/j.biopha.2019.01.050", "ArticleIdList": ["10.1016/j.biopha.2019.01.050", "31382131"]}, {"Citation": "Wang Y. S., Chen C., Zhang S. Y., Li Y., Jin Y. H. (2021). (20S ginsenoside Rh2 inhibits STAT3/VEGF signaling by targeting annexin A2. Int. J. Mol. Sci. 22 (17), 9289. 10.3390/ijms22179289", "ArticleIdList": ["10.3390/ijms22179289", "PMC8431727", "34502195"]}, {"Citation": "Wang Y. S., Zhu H., Li H., Li Y., Zhao B., Jin Y. H. (2019). Ginsenoside compound K inhibits nuclear factor-kappa B by targeting Annexin A2. J. Ginseng Res. 43 (3), 452\u2013459. 10.1016/j.jgr.2018.04.002", "ArticleIdList": ["10.1016/j.jgr.2018.04.002", "PMC6606818", "31308817"]}, {"Citation": "Wang Z., Zhan Y., Xu J., Wang Y., Sun M., Chen J., et al. (2020). \u03b2-Sitosterol reverses multidrug resistance via BCRP suppression by inhibiting the p53-MDM2 interaction in colorectal cancer. J. Agric. Food Chem. 68 (12), 3850\u20133858. 10.1021/acs.jafc.0c00107", "ArticleIdList": ["10.1021/acs.jafc.0c00107", "32167760"]}, {"Citation": "Wilkins L. R., Brautigan D. L., Wu H., Yarmohammadi H., Kubicka E., Serbulea V., et al. (2017). Cinnamic acid derivatives enhance the efficacy of transarterial embolization in a rat model of hepatocellular carcinoma. Cardiovasc. Interv. Radiol. 40 (3), 430\u2013437. 10.1007/s00270-016-1515-y", "ArticleIdList": ["10.1007/s00270-016-1515-y", "PMC5520990", "27872984"]}, {"Citation": "Wu C., Zeng M. H., Liao G., Qian K., Li H. (2020). Neuropilin-1 interacts with fibronectin-1 to promote epithelial-mesenchymal transition progress in gastric cancer. Onco. Targets. Ther. 13, 10677\u201310687. 10.2147/OTT.S275327", "ArticleIdList": ["10.2147/OTT.S275327", "PMC7585825", "33116644"]}, {"Citation": "Wu H. C., Hu Q. R., Luo T., Wei W. C., Wu H. J., Li J., et al. (2021). The immunomodulatory effects of ginsenoside derivative Rh2-O on splenic lymphocytes in H22 tumor-bearing mice is partially mediated by TLR4. Int. Immunopharmacol. 101 (1), 108316. 10.1016/j.intimp.2021.108316", "ArticleIdList": ["10.1016/j.intimp.2021.108316", "34768129"]}, {"Citation": "Wu J. (2017). Effect of ginsenoside triol on PXR-CYP3A4 regulatory pathway in HepG2 cells and its mechanism. Nanchang: Nanchang University, 92."}, {"Citation": "Wu J., Tang X., Shi Y., Ma C., Zhang H., Zhang J., et al. (2022). Crosstalk of LncRNA HOTAIR and SP1-mediated repression of PDK1 contributes to beta-Elemene-inhibited proliferation of hepatocellular carcinoma cells. J. Ethnopharmacol. 283, 114456. 10.1016/j.jep.2021.114456", "ArticleIdList": ["10.1016/j.jep.2021.114456", "34333105"]}, {"Citation": "Wu J., Yao N., Hu Q., Liu M., Zhang H., Xiong Y., et al. (2019). Effect of panaxytriol on cytochrome P450 3A4 via the pregnane X receptor regulatory pathway. Phytother. Res. 33 (4), 968\u2013975. 10.1002/ptr.6290", "ArticleIdList": ["10.1002/ptr.6290", "30653754"]}, {"Citation": "Wu K., Zou L., Lei X., Yang X. (2022). Roles of ABCA1 in cancer. Oncol. Lett. 24 (4), 349. 10.3892/ol.2022.13469", "ArticleIdList": ["10.3892/ol.2022.13469", "PMC9434721", "36072007"]}, {"Citation": "Wu R., Ru Q., Chen L., Ma B., Li C. (2014). Stereospecificity of ginsenoside Rg3 in the promotion of cellular immunity in hepatoma H22-bearing mice. J. Food Sci. 79 (7), H1430\u2013H1435. 10.1111/1750-3841.12518", "ArticleIdList": ["10.1111/1750-3841.12518", "25041540"]}, {"Citation": "Xia T., Zhang B., Li Y., Fang B., Zhu X., Xu B., et al. (2020). New insight into 20(S)-ginsenoside Rh2 against T-cell acute lymphoblastic leukemia associated with the gut microbiota and the immune system. Eur. J. Med. Chem. 203, 112582. 10.1016/j.ejmech.2020.112582", "ArticleIdList": ["10.1016/j.ejmech.2020.112582", "32682197"]}, {"Citation": "Xiao S., Lin Z., Wang X., Lu J., Zhao Y. (2020). Synthesis and cytotoxicity evaluation of panaxadiol derivatives. Chem. Biodivers. 17 (1), e1900516. 10.1002/cbdv.201900516", "ArticleIdList": ["10.1002/cbdv.201900516", "31725193"]}, {"Citation": "Xiaomeng F., Lei L., Jinghong A., Juan J., Qi Y., Dandan Y. (2020). Treatment with \u03b2-elemene combined with paclitaxel inhibits growth, migration, and invasion and induces apoptosis of ovarian cancer cells by activation of STAT-NF-\u03baB pathway. Braz. J. Med. Biol. Res. 53 (6), e8885. 10.1590/1414-431x20208885", "ArticleIdList": ["10.1590/1414-431x20208885", "PMC7228545", "32401925"]}, {"Citation": "Xie J., Luo S., Mi H., Du Y., Bao G., Zhou J., et al. (2019). Intake consumption of ginsenoside Rg3, profiling of selected cytokines, and development of rectal polyps. Cancer Manag. Res. 11, 4059\u20134064. 10.2147/CMAR.S197097", "ArticleIdList": ["10.2147/CMAR.S197097", "PMC6511619", "31190981"]}, {"Citation": "Xiong H., Ni Z., He J., Jiang S., Li X., He J., et al. (2017). LncRNA HULC triggers autophagy via stabilizing Sirt1 and attenuates the chemosensitivity of HCC cells. Oncogene 36 (25), 3528\u20133540. 10.1038/onc.2016.521", "ArticleIdList": ["10.1038/onc.2016.521", "28166203"]}, {"Citation": "Xu J. F., Wan Y., Tang F., Chen L., Yang Y., Xia J., et al. (2021). Emerging significance of ginsenosides as potentially reversal agents of chemoresistance in cancer therapy. Front. Pharmacol. 12, 720474. 10.3389/fphar.2021.720474", "ArticleIdList": ["10.3389/fphar.2021.720474", "PMC8719627", "34975466"]}, {"Citation": "Yang J., Yuan D., Xing T., Su H., Zhang S., Wen J., et al. (2016). Ginsenoside Rh2 inhibiting HCT116 colon cancer cell proliferation through blocking PDZ-binding kinase/T-LAK cell-originated protein kinase. J. Ginseng Res. 40 (4), 400\u2013408. 10.1016/j.jgr.2016.03.007", "ArticleIdList": ["10.1016/j.jgr.2016.03.007", "PMC5052442", "27746693"]}, {"Citation": "Yang L L., Li J., Hu Z., Fan X., Cai T., Hengli Z., et al. (2020). A systematic review of the mechanisms underlying treatment of gastric precancerous lesions by traditional Chinese medicine. Evid. Based. Complement. Altern. Med. 2020, 9154738. 10.1155/2020/9154738", "ArticleIdList": ["10.1155/2020/9154738", "PMC7212333", "32454874"]}, {"Citation": "Yang L L., Zhang X. Y., Li K., Li A. P., Yang W. D., Yang R., et al. (2019). Protopanaxadiol inhibits epithelial-mesenchymal transition of hepatocellular carcinoma by targeting STAT3 pathway. Cell Death Dis. 10 (9), 630. 10.1038/s41419-019-1733-8", "ArticleIdList": ["10.1038/s41419-019-1733-8", "PMC6702205", "31431619"]}, {"Citation": "Yang M., Wang C. C., Wang W. L., Xu J. P., Wang J., Zhang C. H., et al. (2020). Saposhnikovia divaricata-an ethnopharmacological, phytochemical and pharmacological review. Chin. J. Integr. Med. 26 (11), 873\u2013880. 10.1007/s11655-020-3091-x", "ArticleIdList": ["10.1007/s11655-020-3091-x", "PMC7176574", "32328867"]}, {"Citation": "Yang P., Song L., Zhang L., Zhu H., Wang D. (2019). Effects of panaxynol combined with gemcitabine on the differentiation and activity of pancreatic cancer stem cells. J. Jiangsu Univ. Ed. 29 (03), 221\u2013225."}, {"Citation": "Yang Q., Cai N., Che D., Chen X., Wang D. (2020). Ginsenoside Rg3 inhibits the biological activity of SGC-7901. Food Sci. Nutr. 8 (8), 4151\u20134158. 10.1002/fsn3.1707", "ArticleIdList": ["10.1002/fsn3.1707", "PMC7455926", "32884696"]}, {"Citation": "Yang X., Zou J., Cai H., Huang X., Yang X., Guo D., et al. (2017). Ginsenoside Rg3 inhibits colorectal tumor growth via down-regulation of C/EBP\u03b2/NF-\u03baB signaling. Biomed. Pharmacother. 96, 1240\u20131245. 10.1016/j.biopha.2017.11.092", "ArticleIdList": ["10.1016/j.biopha.2017.11.092", "29169725"]}, {"Citation": "Yao H., Wan J. Y., Zeng J., Huang W. H., Sava-Segal C., Li L., et al. (2018). Effects of compound K, an enteric microbiome metabolite of ginseng, in the treatment of inflammation associated colon cancer. Oncol. Lett. 15 (6), 8339\u20138348. 10.3892/ol.2018.8414", "ArticleIdList": ["10.3892/ol.2018.8414", "PMC5950138", "29805567"]}, {"Citation": "Yuan Y., Wang J., Xu M., Zhang Y., Wang Z., Liang L., et al. (2020). 20(S)-ginsenoside Rh2 as agent for the treatment of LMN-CRC via regulating epithelial-mesenchymal transition. Biosci. Rep. 40 (3), BSR20191507. 10.1042/BSR20191507", "ArticleIdList": ["10.1042/BSR20191507", "PMC7098129", "32141497"]}, {"Citation": "Yun U. J., Lee I. H., Lee J. S., Shim J., Kim Y. N. (2020). Ginsenoside Rp1, A ginsenoside derivative, augments anti-cancer effects of actinomycin D via downregulation of an AKT-SIRT1 pathway. Cancers (Basel) 12 (3), E605. 10.3390/cancers12030605", "ArticleIdList": ["10.3390/cancers12030605", "PMC7139315", "32151067"]}, {"Citation": "Zeng J., Ma X., Zhao Z., Chen Y., Wang J., Hao Y., et al. (2021). Ginsenoside Rb1 lessens gastric precancerous lesions by interfering with beta-catenin/TCF4 interaction. Front. Pharmacol. 12, 682713. 10.3389/fphar.2021.682713", "ArticleIdList": ["10.3389/fphar.2021.682713", "PMC8476751", "34594214"]}, {"Citation": "Zhang E., Shi H., Yang L., Wu X., Wang Z. (2017). Ginsenoside Rd regulates the Akt/mTOR/p70S6K signaling cascade and suppresses angiogenesis and breast tumor growth. Oncol. Rep. 38 (1), 359\u2013367. 10.3892/or.2017.5652", "ArticleIdList": ["10.3892/or.2017.5652", "28534996"]}, {"Citation": "Zhang F., Li M., Wu X., Hu Y., Cao Y., Wang X., et al. (2015). 20(S)-ginsenoside Rg3 promotes senescence and apoptosis in gallbladder cancer cells via the p53 pathway. Drug Des. devel. Ther. 9, 3969\u20133987. 10.2147/DDDT.S84527", "ArticleIdList": ["10.2147/DDDT.S84527", "PMC4539091", "26309394"]}, {"Citation": "Zhang F., Xu H., Xia R., Yu P., Li Y., Yu X., et al. (2021). Pseudo-ginsenoside Rh2 induces protective autophagy in hepatocellular carcinoma HepG2 cells. Recent Pat. anticancer. Drug Discov. 16 (4), 521\u2013532. 10.2174/1574892816666210607100239", "ArticleIdList": ["10.2174/1574892816666210607100239", "34109916"]}, {"Citation": "Zhang H., Yi J. K., Huang H., Park S., Kwon W., Kim E., et al. (2022). 20 (S)-ginsenoside Rh2 inhibits colorectal cancer cell growth by suppressing the Axl signaling pathway in vitro and in vivo . J. Ginseng Res. 46 (3), 396\u2013407. 10.1016/j.jgr.2021.07.004", "ArticleIdList": ["10.1016/j.jgr.2021.07.004", "PMC9120647", "35600769"]}, {"Citation": "Zhang J., Li W., Yuan Q., Zhou J., Zhang J., Cao Y., et al. (2019). Transcriptome analyses of the anti-proliferative effects of 20(S)-Ginsenoside Rh2 on HepG2 cells. Front. Pharmacol. 10, 1331. 10.3389/fphar.2019.01331", "ArticleIdList": ["10.3389/fphar.2019.01331", "PMC6855211", "31780945"]}, {"Citation": "Zhang J., Ma X., Fan D. (2022). Ginsenoside CK ameliorates hepatic lipid accumulation via activating the LKB1/AMPK pathway in vitro and in vivo . Food Funct. 13 (3), 1153\u20131167. 10.1039/d1fo03026d", "ArticleIdList": ["10.1039/d1fo03026d", "35018944"]}, {"Citation": "Zhang J., Ma X., Fan D. (2021). Ginsenoside CK inhibits hypoxia-induced epithelial-mesenchymal transformation through the HIF-1\u03b1/NF-\u03baB feedback pathway in hepatocellular carcinoma. Foods 10 (6), 1195. 10.3390/foods10061195", "ArticleIdList": ["10.3390/foods10061195", "PMC8227303", "34073155"]}, {"Citation": "Zhang K K., Liu Y., Wang C., Li J., Xiong L., Wang Z., et al. (2019). Evaluation of the gastroprotective effects of 20 (S)-ginsenoside Rg3 on gastric ulcer models in mice. J. Ginseng Res. 43 (4), 550\u2013561. 10.1016/j.jgr.2018.04.001", "ArticleIdList": ["10.1016/j.jgr.2018.04.001", "PMC6823781", "31695563"]}, {"Citation": "Zhang L. (2021). Mechanism of upregulation of CYP3A4 expression by ginsenosperm triol based on the interaction of PXR, CAR with HSP90 and RXR. Nanchang: Nanchang University, 80."}, {"Citation": "Zhang R., Pan T., Xiang Y., Zhang M., Feng J., Liu S., et al. (2020). \u03b2-Elemene reverses the resistance of p53-deficient colorectal cancer cells to 5-fluorouracil by inducing pro-death autophagy and cyclin D3-dependent cycle arrest. Front. Bioeng. Biotechnol. 8, 378. 10.3389/fbioe.2020.00378", "ArticleIdList": ["10.3389/fbioe.2020.00378", "PMC7225311", "32457882"]}, {"Citation": "Zhang S., Wang H., Shi Z., Zhang L., Song Y., Yue W. (2007). Application of gene chip technology to study the target gene regulation of Hedyotis diffusa stigmasterol in inhibiting the growth of human hepatoma cells in vitro . Prog. Mod. Biomed. 1 (08), 1181\u20131183."}, {"Citation": "Zhang S., Zhang M., Chen J., Zhao J., Su J., Zhang X. (2020). Ginsenoside compound K regulates HIF-1\u03b1-Mediated glycolysis through Bclaf1 to inhibit the proliferation of human liver cancer cells. Front. Pharmacol. 11, 583334. 10.3389/fphar.2020.583334", "ArticleIdList": ["10.3389/fphar.2020.583334", "PMC7753211", "33363466"]}, {"Citation": "Zhang X. F., Li K. K., Gao L., Li S. Z., Chen K., Zhang J. B., et al. (2015). miR-191 promotes tumorigenesis of human colorectal cancer through targeting C/EBP\u03b2. Oncotarget 6 (6), 4144\u20134158. 10.18632/oncotarget.2864", "ArticleIdList": ["10.18632/oncotarget.2864", "PMC4414178", "25784653"]}, {"Citation": "Zhang X., Sun K., Zhu Q., Song T., Liu Y. (2017b). Ginseng polysaccharide serves as a potential radiosensitizer through inducing apoptosis and autophagy in the treatment of osteosarcoma. Kaohsiung J. Med. Sci. 33 (11), 535\u2013542. 10.1016/j.kjms.2017.07.001", "ArticleIdList": ["10.1016/j.kjms.2017.07.001", "29050670"]}, {"Citation": "Zhang X. Y., Sun K., Zhu Q., Song T., Liu Y. (2017a). Ginseng polysaccharide serves as a potential radiosensitizer through inducing apoptosis and autophagy in the treatment of osteosarcoma. Kaohsiung J. Med. Sci. 33 (11), 535\u2013542. 10.1016/j.kjms.2017.07.001", "ArticleIdList": ["10.1016/j.kjms.2017.07.001", "29050670"]}, {"Citation": "Zhang X., Zhang S., Sun Q., Jiao W., Yan Y., Zhang X. (2018). Compound K induces endoplasmic reticulum stress and apoptosis in human liver cancer cells by regulating STAT3. Molecules 23 (6), E1482. 10.3390/molecules23061482", "ArticleIdList": ["10.3390/molecules23061482", "PMC6099685", "29921768"]}, {"Citation": "Zhang Z., Bo J., Xiaoxiang Z. (2004). In vitro immune enhancing effect of ginsenoside Rg_3 on peripheral blood lymphocytes in patients treated with tumor radiotherapy. Chin. Pharm. J. 1 (04), 25\u201328."}, {"Citation": "Zhao H. D., Xie H. J., Li J., Ren C. P., Chen Y. X. (2018). Research progress on reversing multidrug resistance in tumors by using Chinese medicine. Chin. J. Integr. Med. 24 (6), 474\u2013480. 10.1007/s11655-018-2910-1", "ArticleIdList": ["10.1007/s11655-018-2910-1", "29860581"]}, {"Citation": "Zhao H., Zhang X., Wang M., Lin Y., Zhou S. (2021). Stigmasterol simultaneously induces apoptosis and protective autophagy by inhibiting akt/mTOR pathway in gastric cancer cells. Front. Oncol. 11, 629008. 10.3389/fonc.2021.629008", "ArticleIdList": ["10.3389/fonc.2021.629008", "PMC7940753", "33708631"]}, {"Citation": "Zhao J. (2020). Extraction, separation, purification, structural characterization and immune anti-tumor mechanism of ginseng polysaccharide. Changchun: Jilin Agricultural University, 105."}, {"Citation": "Zhao X. Y., He Z. Y., Zai S. F. (2020). [Effects of ginsenoside Rg5 on cell cycle and invasion of gastric cancer]. Zhongguo Ying Yong Sheng Li Xue Za Zhi 36 (1), 51\u201354. 10.12047/j.cjap.5891.2020.011", "ArticleIdList": ["10.12047/j.cjap.5891.2020.011", "32476373"]}, {"Citation": "Zhao Y., Chang S. K., Qu G., Li T., Cui H. (2009). Beta-sitosterol inhibits cell growth and induces apoptosis in SGC-7901 human stomach cancer cells. J. Agric. Food Chem. 57 (12), 5211\u20135218. 10.1021/jf803878n", "ArticleIdList": ["10.1021/jf803878n", "19456133"]}, {"Citation": "Zheng K., Li Y., Wang S., Wang X., Liao C., Hu X., et al. (2016). Inhibition of autophagosome-lysosome fusion by ginsenoside Ro via the ESR2-NCF1-ROS pathway sensitizes esophageal cancer cells to 5-fluorouracil-induced cell death via the CHEK1-mediated DNA damage checkpoint. Autophagy 12 (9), 1593\u20131613. 10.1080/15548627.2016.1192751", "ArticleIdList": ["10.1080/15548627.2016.1192751", "PMC5082787", "27310928"]}, {"Citation": "Zhong J., Chen H., Ye D., Deng Z., Shao J., Han J., et al. (2022). [Molecular mechanism of Ganoderma against gastric cancer based on network pharmacology and experimental test]. China J. Chin. Materia Medica 47 (01), 203\u2013223. 10.19540/j.cnki.cjcmm.20210902.701", "ArticleIdList": ["10.19540/j.cnki.cjcmm.20210902.701", "35178927"]}, {"Citation": "Zhou Y., Zheng X., Lu J., Chen W., Li X., Zhao L. (2018). Ginsenoside 20(S)-Rg3 inhibits the warburg effect via modulating DNMT3A/MiR-532-3p/HK2 pathway in ovarian cancer cells. Cell. Physiol. biochem. 45 (6), 2548\u20132559. 10.1159/000488273", "ArticleIdList": ["10.1159/000488273", "29558748"]}, {"Citation": "Zhu H., Liu H., Zhu J. H., Wang S. Y., Zhou S. S., Kong M., et al. (2021a). Efficacy of ginseng and its ingredients as adjuvants to chemotherapy in non-small cell lung cancer. Food Funct. 12 (5), 2225\u20132241. 10.1039/d0fo03341c", "ArticleIdList": ["10.1039/d0fo03341c", "33595586"]}, {"Citation": "Zhu H., Wang S. Y., Zhu J. H., Liu H., Kong M., Mao Q., et al. (2021b). Efficacy and safety of transcatheter arterial chemoembolization combined with ginsenosides in hepatocellular carcinoma treatment. Phytomedicine. 91, 153700. 10.1016/j.phymed.2021.153700", "ArticleIdList": ["10.1016/j.phymed.2021.153700", "34425474"]}, {"Citation": "Zhu J., Li B., Ji Y., Zhu L., Zhu Y., Zhao H. (2019). \u03b2\u2011elemene inhibits the generation of peritoneum effusion in pancreatic cancer via suppression of the HIF1A\u2011VEGFA pathway based on network pharmacology. Oncol. Rep. 42 (6), 2561\u20132571. 10.3892/or.2019.7360", "ArticleIdList": ["10.3892/or.2019.7360", "PMC6826333", "31638231"]}, {"Citation": "Zhuang J., Yin J., Xu C., Mu Y., Lv S. (2018). 20(S)-Ginsenoside Rh2 induce the apoptosis and autophagy in U937 and K562 cells. Nutrients 10 (3), E328. 10.3390/nu10030328", "ArticleIdList": ["10.3390/nu10030328", "PMC5872746", "29518056"]}, {"Citation": "Zou J., Su H., Zou C., Liang X., Fei Z. (2020). Ginsenoside Rg3 suppresses the growth of gemcitabine-resistant pancreatic cancer cells by upregulating lncRNA-CASC2 and activating PTEN signaling. J. Biochem. Mol. Toxicol. 34 (6), e22480. 10.1002/jbt.22480", "ArticleIdList": ["10.1002/jbt.22480", "32104955"]}, {"Citation": "Zwolak I. (2020). Protective effects of dietary antioxidants against vanadium-induced toxicity: A review. Oxid. Med. Cell. Longev. 2020, 1490316. 10.1155/2020/1490316", "ArticleIdList": ["10.1155/2020/1490316", "PMC6973198", "31998432"]}], "ReferenceList": []}], "History": [{"Year": "2022", "Month": "9", "Day": "4"}, {"Year": "2022", "Month": "10", "Day": "3"}, {"Year": "2022", "Month": "10", "Day": "31", "Hour": "4", "Minute": "56"}, {"Year": "2022", "Month": "11", "Day": "1", "Hour": "6", "Minute": "0"}, {"Year": "2022", "Month": "11", "Day": "1", "Hour": "6", "Minute": "1"}, {"Year": "2022", "Month": "10", "Day": "12"}], "PublicationStatus": "epublish", "ArticleIdList": ["36313365", "PMC9603756", "10.3389/fphar.2022.1036498", "1036498"]}}], "PubmedBookArticle": []}